Functional diversity of human intrinsically photosensitive retinal ganglion cells

The discovery of melanopsin, a blue-light-sensing receptor, in frog skin and mice eyes led to real-world applications, from lighting design to tinted eyeglasses. But mice are nocturnal, and their eyes function differently from ours. No one had studied how melanopsin-producing neurons in the human retina actually respond to light.

Studying melanopsin in human retina is extremely difficult: it requires retina kept alive long enough to test, the light-sensing neurons are sparse and nearly impossible to identify under a microscope, and any electrical signal detected must be verified as melanopsin-driven rather than something else.

The breakthrough came from a team overcoming four key challenges: collecting eyes from organ donors soon after death, developing a method to keep the retina alive for hours, using hundreds of electrodes to sample the retina broadly for melanopsin signals, and creating a lab-made molecule that specifically blocks melanopsin function. Many nights brought no results as we refined the methods.

Finally, one night the retina responded when illuminated with blue light — and using our melanopsin-blocking drug, we confirmed the signal was melanopsin's. These cells responded on their own, without help from rods or cones, signaling in a slow, sustained way rather than quick flashes. We found several distinct types, each behaving differently: some sense blue light in low-light conditions, others need very bright light to activate; some turn off soon after the light does, while others keep signaling for seconds afterward. In short, the human eye contains not one but many types of blue-light-sensing neurons, each tuned to different lighting conditions.

This finding turns general advice about light into actionable routines — tunable lighting to treat depression, delirium, and dementia. It explains why bright morning light helps you feel awake, why screens and lamps at night push your body clock later, and why the color and intensity of light matter wherever people need to sleep and recover — hospital wards, schools, homes.

The study yielded an unexpected and far-reaching bonus. The techniques and protocols we developed to keep retina alive and responsive were refined further in a follow-up foundational study, which demonstrated how to revive human retinal function after death. That work opens the door to a future once thought out of reach: transplanting human retina to restore sight in people with blindness.